General Court 3 May 2018, Case T-662/16: Judgment of the General Court of 3 May 2018 — Gall Pharma v EUIPO — Pfizer (Styriagra) (EU trade mark — Opposition proceedings — Application for EU word mark Styriagra — Earlier EU word mark VIAGRA — Taking unfair advantage of the distinctive character or repute of the earlier mark — Article 8(5) of Regulation (EC) No 207/2009 (now Article 8(5) of Regulation (EU) 2017/1001))
Also known as
European Union · · · 03-05-2018
201806080161931422018/C 221/206622016TC22120180625EN01ENINFO_JUDICIAL20180503181811Case T-662/16: Judgment of the General Court of 3 May 2018 — Gall Pharma v EUIPO — Pfizer (Styriagra) (EU trade mark — Opposition proceedings — Application for EU word mark Styriagra — Earlier EU word mark VIAGRA — Taking unfair advantage of the distinctive character or repute of the earlier mark — Article 8(5) of
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit